Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001663577-26-000156
Filing Date
2026-05-20
Accepted
2026-05-20 16:42:52
Documents
50
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bpth_10q1033126.htm   iXBRL 10-Q 470323
2 CERTIFICATION ex31.htm EX-31 10490
3 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, ex32.htm EX-32 4940
  Complete submission text file 0001663577-26-000156.txt   2700200

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bpth-20260331.xsd EX-101.SCH 30401
5 XBRL CALCULATION FILE bpth-20260331_cal.xml EX-101.CAL 30212
6 XBRL DEFINITION FILE bpth-20260331_def.xml EX-101.DEF 59728
7 XBRL LABEL FILE bpth-20260331_lab.xml EX-101.LAB 182776
8 XBRL PRESENTATION FILE bpth-20260331_pre.xml EX-101.PRE 147590
54 EXTRACTED XBRL INSTANCE DOCUMENT bpth_10q1033126_htm.xml XML 255937
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

EIN.: 870652870 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 261004702
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)